My ePortfolio Register   


19 - 21 Mar

Mercure Hotel MOA, Berlin, Germany


March 2018

Mon Tue Wed Thu Fri Sat Sun
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

The Cancer Drug Development Forum (CDDF) in collaboration with the Society for Immunotherapy of Cancer (SITC) has the great pleasure to invite you to take part in the 5th Immunotherapy of Cancer Conference (ITOC5) – the leading International conference in Europe providing a global platform for translational research in the field of immuno-oncology.

The ITOC series of conferences is the premier meeting for education, scientific exchange, and networking within the cancer immunotherapy field.

It aims at providing a forum for all professionals working in immunotherapy to discuss early clinical drug development and address the unique challenges of translational research.

The programme will focus on the latest challenges and innovations with a special emphasis on combination therapy, immuno-monitoring and biomarker development.

At this conference, we are in particular addressing preclinical and clinical scientists, clinical investigators, postdoctoral fellows involved in cancer research, regulatory scientists, healthcare professionals and the pharmaceutical industry

Join us in Berlin, Germany on 19 – 21 March 2018 to help push further the opportunities that will ultimately aid in revolutionising the way cancer is treated.

More information is available from the Conference Web Site

ecancer is filming at this event, to sign up for coverage click on the box to the right

Add to Outlook / iCal

There is currently no content available for ITOC5. Please visit this page again soon.

More conferences from this month

Date Conference Country
01 - 02 Mar ecancer Spain 2018
ecancer Spain 2018
02 - 03 Mar EAFO Thyroid Cancer Forum
EAFO Thyroid Cancer Forum
05 - 07 Mar TAT 2018 - Targeted Anticancer Therapies
TAT 2018 - Targeted Anticancer Therapies
12 - 14 Mar 2nd EACR conference on Radiation Break-through: from DNA damage responses to precision cancer therapy
2nd EACR conference on Radiation Break-through: from DNA damage responses to precision cancer therapy
United Kingdom
19 - 21 Mar ITOC5
21 - 23 Mar EBCC 11
24 - 25 Mar EAFO Pancreatic Cancer Forum
EAFO Pancreatic Cancer Forum
23 - 29 Mar Signalling Pathways 2018
Signalling Pathways 2018

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence